Covetrus (NASDAQ:CVET) had its price target lowered by Stifel Nicolaus from $30.00 to $18.00 in a report issued on Wednesday, The Fly reports. The brokerage currently has a hold rating on the stock.
A number of other brokerages have also commented on CVET. Zacks Investment Research lowered Covetrus from a buy rating to a hold rating in a research note on Wednesday, July 17th. Cleveland Research started coverage on Covetrus in a research note on Friday, May 10th. They set a hold rating for the company. Guggenheim started coverage on Covetrus in a research note on Thursday, May 23rd. They set a neutral rating for the company. Finally, ValuEngine lowered Covetrus from a buy rating to a hold rating in a research note on Tuesday. Six equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and an average target price of $25.75.
Covetrus stock traded up $1.61 during midday trading on Wednesday, reaching $13.96. 1,404,832 shares of the stock traded hands, compared to its average volume of 959,482. The business’s fifty day moving average price is $23.76. Covetrus has a 12 month low of $12.22 and a 12 month high of $43.83. The company has a current ratio of 1.82, a quick ratio of 0.93 and a debt-to-equity ratio of 0.51.
Covetrus, Inc engages in developing technologies and services for animal health industry. It also provides products, software, and services to help drive improved patient health, strong client relationships, and successful financial outcomes for veterinary professionals. The company was founded on April 13, 2018 and is headquartered in Melville, NY.
Featured Story: Do You Need a Fiduciary?
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.